Login to Your Account



Other News To Note


Wednesday, November 21, 2012
• NeoStem Inc., of New York, said it was awarded a two-year grant totaling $1.2 million to study the repair of bone defects with human autologous pluripotent very small embryonic-like (VSEL) stem cells from the National Institute of Dental and Craniofacial Research.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription